서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 13 of 13

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2021-01	Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy Yoo, Shin Hye; Kang, Seo Young; Yoon, Jeesun; Kim, Tae-Yong; Cheon, Gi Jeong; Oh, Do-Youn Scientific Reports, Vol.11 No.1, p. 296	DOI
2021-04	Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer Yoon, Jeesun; Kang, Seo Young; Lee, Kyung-Hun; Cheon, Gi Jeong; Oh, Do-Youn Cancer Research and Treatment, Vol.53 No.2, pp.471-479	DOI
2021-09	WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers Jin, Mei-Hua; Nam, Ah-Rong; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Kim, Jae-Min; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn Gastric Cancer, Vol.24 No.5, pp.1003-1020	DOI
2021-09	ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer Nam, Ah-Rong; Yoon, Jeesun; Jin, Mei-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Kim, Jae-Min; Kim, Tae-Yong; Oh, Do-Youn Cancer Letters, Vol.516, pp.38-47	DOI
2022-04	Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer Seo, Hye-Rim; Nam, Ah-Rong; Bang, Ju-Hee; Oh, Kyoung-Seok; Kim, Jae-Min; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn Cancer Research and Treatment, Vol.54 No.2, pp.541-553	DOI
2022-06	Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study Oh, Do-Youn; Lee, Kyung-Hun; Lee, Dae-Won; Yoon, Jeesun; Kim, Tae-Yong; Bang, Ju-Hee; Nam, Ah-Rong; Oh, Kyoung-Seok; Kim, Jae-Min; Lee, Young; Guthrie, Violeta; McCoon, Patricia; Li, Weimin; Wu, Song; Zhang, Qu; Rebelatto, Marlon C; Kim, Jin Won The Lancet Gastroenterology & Hepatology, Vol.7 No.6, pp.522-532	DOI
2022-08	A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers Oh, Kyoung-Seok; Nam, Ah-Rong; Bang, Ju-Hee; Seo, Hye-Rim; Kim, Jae-Min; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn Oncogene, Vol.41 No.32, pp.3939-3952	DOI
2023-01	Recent Progress in Immunotherapy for Gastric Cancer Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn Journal of Gastric Cancer, Vol.23 No.1, pp.207-223	DOI
2023-05	Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment Kwon, Hyun Jung; Park, Yujun; Nam, Soo Kyung; Kang, Enoch; Kim, Ka-Kyung; Jeong, Inhae; Kwak, Yoonjin; Yoon, Jeesun; Kim, Tae-Yong; Lee, Keun-Wook; Oh, Do-Youn; Im, Seock-Ah; Kong, Seong-Ho; Park, Do Joong; Lee, Hyuk-Joon; Kim, Hyung-Ho; Yang, Han-Kwang; Lee, Hye Seung Cancer Medicine, Vol.12 No.9, pp.1-14	DOI
2024-09	HER2-targeted therapies beyond breast cancer - an update Yoon, Jeesun; Oh, Do-Youn NATURE REVIEWS CLINICAL ONCOLOGY, Vol.21 No.9, pp.675-700	DOI
2024-10	Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX Kim, Min Kyu; Cho, In Rae; Kim, Yooeun; Choi, Jin Ho; Jung, Kwangrok; Kim, Jaihwan; Kim, Sheehyun; Yun, Hongseok; Yoon, Jeesun; Oh, Do-Youn; Kim, Kwangsoo; Lee, Sang Hyub Therapeutic Advances in Medical Oncology, Vol.16, pp.1-14	DOI
2024-10	Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells Oh, Kyoung-Seok; Nam, Ah-Rong; Bang, Ju-Hee; Jeong, Yoojin; Choo, Sea Young; Kim, Hyo Jung; Lee, Su In; Kim, Jae-Min; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn CELL COMMUNICATION AND SIGNALING, Vol.22 No.1, p. 518	DOI
2025-02	An International Comparative Study on Parody as Fair Use in Copyright Law: Lee Sang-bong Exhibition Poster Yoon, Jeesun; Eune, Juhyun 디자인학연구, Vol.38 No.1, pp.335-345	DOI

1